MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
LumiraDx (LMDX)
Organization & Developments: LumiraDx
Parents
LumiraDx (LMDX)
Children
*A microfluidic immunofluorescence assay that can detect SARS-CoV-2 and influenza A/B expected to have sensitivity approaching laboratory PCR.
*Multiplexed assay results are provided in less than 15 minutes.
*The firm is commercializing point of care diagnostic tests, including one for the COVID-19 virus.
*The test is intended for use in point-of-care settings.
2023: LumiraDx to reduce headcount by ~40%_seekingalpha
2023: Roche to buy part of LumiraDx diagnostics platform for $295 million
Jumps
Finance & Acquisitions: LumiraDx
Key People: LumiraDx